Antiemetics: all 820 studies that test it

Page 3 of 9. Open to participants first (71), then studies with results posted, then the rest; newest registration first within each.

• Aprepitant and Granisetron for the Prophylaxis of Radiation Induced Nausea and Vomiting - A Pilot StudyTerminatedNCT01183481Phase 2Results posted
• Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin TrialCompletedNCT01149369Phase 2Results posted
• Additional Anti-emetic Effect of Ramosetron Prophylaxis After Total Knee ArthroplastyCompletedNCT01102491Phase 4Results posted
• Ondansetron Plus Dexamethasone With or Without Metoclopramide as Antiemetic Prophylaxis After Receiving CisplatinCompletedNCT01093690Not applicableResults posted
• A Study of Palonosetron for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV) in Participants Who Have Experienced CINV(Chemotherapy-Induced Nausea and Vomiting) During the Previous Cycle of Low Emetogenic Chemotherapy (LEC)CompletedNCT01054456Phase 2Results posted
• Fosaprepitant Dimeglumine in Treating Patients With Nausea and Vomiting Caused By ChemotherapyTerminatedNCT01031953Phase 1/2Results posted
• Palonosetron Versus Ondansetron for the Prevention of Nausea and VomitingCompletedNCT01031498Phase 2Results posted
• Safety and Efficacy of Aprepitant, Ramosetron, and Dexamethasone for Chemotherapy-Induced Nausea and Vomiting in Patients With Ovarian Cancer Treated With Taxane/CarboplatinCompletedNCT01012336Phase 2Results posted
• Metoclopramide Versus Ketorolac for Tension-type HeadacheCompletedNCT01011673Phase 4Results posted
• Functional Magnetic Resonance Imaging of Opioid Withdrawal in Healthy Human VolunteersCompletedNCT01006707Not applicableResults posted
• Aprepitant Effects on Oxycodone ResponseCompletedNCT00999544Not applicableResults posted
• A Study to Investigate the Safety and Tolerability of MK-0517 in Healthy Subjects (MK-0517-012)CompletedNCT00990821Phase 1Results posted
• Palonosetron for the Treatment of Nausea and Vomiting in Terminally Ill PatientsTerminatedNCT00982995Phase 2Results posted
• Bioequivalence of Two Formulations of Ondansetron in Healthy Adults (0869-106)CompletedNCT00972595Phase 1Results posted
• Pilot Study to Assess Palonosetron Versus Ondansetron as Rescue Medication in Subjects That Develop Postoperative Nausea and Vomiting (PONV) in the Postanesthesia Care Unit (PACU)CompletedNCT00967499Phase 2Results posted
• Ondansetron Versus Aprepitant Plus Ondansetron for EmesisCompletedNCT00954941Phase 2Results posted
• Aprepitant/MK0869 for Prevention of Chemotherapy Induced Nausea and Vomiting Associated With Cisplatin (0869-169)(COMPLETED)CompletedNCT00952341Phase 3Results posted
• Efficacy of IV Palo With IV Dexamethasone vs IV Palo for Prevention of Immediate & Delayed PONVCompletedNCT00952133Phase 4Results posted
• A Study to Assess the Bioequivalence of Aprepitant and Fosaprepitant and the Effect of Food on Aprepitant Bioavailability (0869-165)CompletedNCT00945321Phase 1Results posted
• Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting ConditionsCompletedNCT00934921Phase 1Results posted
• Ondansetron HCl Orally Disintegrating Tablets Under Fasting ConditionsCompletedNCT00934180Phase 1Results posted
• Palonosetron Hydrochloride in Preventing Nausea and Vomiting Caused by Radiation Therapy in Patients With Primary Abdominal CancerTerminatedNCT00903396Phase 2Results posted
• Intravenous Palonosetron With Radiotherapy and Concomitant TemozolomideCompletedNCT00900757Phase 2Results posted
• The Effect of NK1R Antagonism on Alcohol Craving and PTSD Symptoms in Alcohol Dependent Patients With PTSDCompletedNCT00896038Phase 2Results posted
• Fosaprepitant Dimeglumine, Palonosetron Hydrochloride, and Dexamethasone in Preventing Nausea and Vomiting Caused by Cisplatin in Patients With Stage III or Stage IV Head and Neck Cancer Undergoing Chemotherapy and Radiation TherapyTerminatedNCT00895245Phase 2Results posted
• Aprepitant for Prevention of Postoperative Nausea and Vomiting in Elective HysterectomyTerminatedNCT00888329Phase 4Results posted
• Antiemetic Prophylaxis for Postdischarge Nausea and Vomiting After Hip ArthroscopyCompletedNCT00878228Phase 4Results posted
• Efficacy and Safety of Metoclopramide Nasal Spray Solution in Diabetic Patients With GastroparesisCompletedNCT00845858Phase 2Results posted
• Granisetron 1 mg Tablets Under Fasting ConditionsCompletedNCT00834717Phase 1Results posted
• Granisetron 1 mg Tablets, Non-fastingCompletedNCT00834522Phase 1Results posted
• Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric PatientsCompletedNCT00828295Phase 3Results posted
• A Study of Aprepitant (MK-0869) in Pediatric Participants Undergoing Surgery (MK-0869-148)CompletedNCT00819039Phase 1Results posted
• A Study of MK-0869 (Aprepitant) and MK-0517 (Fosaprepitant) in Pediatric Participants Receiving Chemotherapy (MK-0869-134)TerminatedNCT00818259Phase 1Results posted
• A Study in the Treatment of Alcohol Dependence.CompletedNCT00805441Phase 2Results posted
• Ondansetron in Preventing Nausea and Vomiting in Patients Undergoing Stem Cell TransplantCompletedNCT00795769Phase 2Results posted
• Phase 2 Study of Efficacy, Tolerability, and Safety of Intranasal Granisetron for Chemo-Induced Nausea and VomitingCompletedNCT00787566Phase 2Results posted
• Domperidone in Refractory GastroparesisTerminatedNCT00760461Phase 2Results posted
• A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) PancreatitisCompletedNCT00736073Not applicableResults posted
• Aprepitant With Dexamethasone Versus Ondansetron With Dexamethasone for PONV Prophylaxis in Patients Having CraniotomyCompletedNCT00734929Phase 4Results posted
• Comparison of Aprepitant Versus Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and VomitingCompletedNCT00717054Not applicableResults posted
• Emend for Multiple-day Emetogenic ChemotherapyCompletedNCT00711555Phase 2Results posted
• New Medication Treatment for Stimulant DependenceCompletedNCT00689572Phase 2Results posted
• Metoclopramide for Migraine: A Dose Finding StudyCompletedNCT00682734Phase 3Results posted
• Palonosetron and Hydroxyzine to Reduce Opioid WithdrawalCompletedNCT00661674Not applicableResults posted
• Aprepitant for PONV Prophylaxis in Outpatient Plastic SurgeryCompletedNCT00659945Phase 4Results posted
• Comparison of Oral Aprepitant and Transdermal Scopolamine for Preventing Postoperative Nausea and VomitingCompletedNCT00659737Not applicableResults posted
• Comparison of Ondansetron, Metoclopramide and Promethazine for the Treatment of Nausea and Vomiting in the Adult EDTerminatedNCT00655642Not applicableResults posted
• Aprepitant's Effect on Drug Metabolism in Multi-Day Combination (CHOP/R-CHOP) Chemotherapy Regimen in Lymphoma PatientsCompletedNCT00651755Not applicableResults posted
• Aloxi for Prevention of Chemotherapy Induced Nausea and Vomiting in Malignant Glioma Patients Receiving Irinotecan With BevacizumabTerminatedNCT00636805Phase 2Results posted
• Evaluation of Fosaprepitant (MK0517) in Single Dose Schedule (0517-017)CompletedNCT00619359Phase 3Results posted
• The Efficacy Of Diclectin® For Nausea And Vomiting Of PregnancyCompletedNCT00614445Phase 3Results posted
• Staccato Prochlorperazine Single Dose PK StudyCompletedNCT00610727Phase 1Results posted
• A Study Of IV Casopitant For The Prevention Of Chemotherapy Induced Nausea And Vomiting.CompletedNCT00601172Phase 3Results posted
• Multi-day Doses in Prevention of Nausea and EmesisCompletedNCT00600353Phase 2Results posted
• Ondansetron vs Prochlorperazine for Nausea and Vomiting in the Emergency DepartmentCompletedNCT00590317Phase 2Results posted
• Aprepitant + a 5HT3 + Dexamethasone in Patients With Germ Cell TumorsCompletedNCT00572572Phase 3Results posted
• Domperidone for Gastroparesis in Solid Organ TransplantationTerminatedNCT00552422Not applicableResults posted
• Staccato Prochlorperazine Thorough QT/QTcCompletedNCT00543062Phase 1Results posted
• Safety/Efficacy of Tigan® to Control Nausea/Vomiting Experienced During Apokyn® Initiation and TreatmentCompletedNCT00489255Phase 4Results posted
• The Montefiore Metoclopramide StudyCompletedNCT00475306Phase 4Results posted
• Prevention of Delayed Nausea A Phase III Double-Blind Placebo-Controlled Clinical TrialCompletedNCT00475085Phase 3Results posted
• Effectiveness of Tropisetron Plus Risperidone for Improving Cognitive and Perceptual Disturbances in SchizophreniaCompletedNCT00435370Phase 3Results posted
• Palonosetron for Prevention of Biochemotherapy Induced Nausea and VomitingCompletedNCT00412425Phase 1/2Results posted
• Palonosetron in Sarcoma Patients Receiving Chemotherapy With Adriamycin and Ifosfamide (AI)CompletedNCT00410488Not applicableResults posted
• The CRISIS Prevention StudyTerminatedNCT00395161Phase 3Results posted
• Substance P Antagonist in the Treatment of Posttraumatic Stress DisorderCompletedNCT00383786Phase 2Results posted
• Phase II Trial of Aprepitant & Palonosetron for CINV Prevention w FOLFOXCompletedNCT00381862Phase 2Results posted
• The Antidepressant Efficacy of the Anticholinergic ScopolamineTerminatedNCT00369915Phase 2Results posted
• Treatment of Acute Migraine Headache in ChildrenCompletedNCT00355394Phase 2Results posted
• Dexamethasone and Ondansetron Hydrochloride or Palonosetron Hydrochloride in Preventing Nausea and Vomiting in Patients Receiving Doxorubicin Hydrochloride and Cyclophosphamide For Early Stage Breast CancerCompletedNCT00343863Not applicableResults posted
• Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)CompletedNCT00337727Phase 3Results posted
• Effect of LY686017 on Alcohol CravingCompletedNCT00310427Phase 2Results posted
• Aprepitant, Granisetron, & Dexamethasone in Preventing Nausea & Vomiting in Pts. Receiving Cyclophosphamide Before a Stem Cell TransplantCompletedNCT00293384Not applicableResults posted
• Aprepitant in Preventing Nausea and Vomiting in Patients Who Are Undergoing a Stem Cell TransplantCompletedNCT00248547Not applicableResults posted
• A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)CompletedNCT00231777Phase 3Results posted
• A Study of Kytril (Granisetron) in the Prevention of Post-Operative Nausea and Vomiting (PONV) in Pediatric Subjects Undergoing Tonsillectomy or AdenotonsillectomyCompletedNCT00231478Phase 4Results posted
• Prophylactic Ondansetron for Preventing Spinal Anesthesia-Induced Hypotension in Elective Cesarean SectionCompletedNCT07886151Phase 4
• Prophylactic Ondansetron and Maternal Hemodynamics During Spinal Anesthesia for Elective Cesarean SectionCompletedNCT07883772Not applicable
• Fosrolapitant and Palonosetron for Highly Emetogenic ADC-Induced Nausea and Vomiting in Solid TumorsActive, not recruitingNCT07841210Phase 2
• Occlusal Splint Combined With Granisetron Injection for Management of Myofascial Pain Related to Temporomandibular DisordersActive, not recruitingNCT07401745Phase 4
• Date Fruit Benefits to Treat Morning Sickness in First Trimester of PregnancyActive, not recruitingNCT07354529Not applicable
• Effect of Ondansetron on Patient Tolerance, Efficacy and Endoscopist Workload in Unsedated Endoscopy for Upper Gastrointestinal BleedingCompletedNCT07336680Phase 4
• Comparison of Intravenous Ondansetron and Low Dose Ketamine in Preventing Post Spinal ShiveringCompletedNCT07334223Not applicable
• Oral Ondansetron to Improve Patient Experience of Unsedated Esophagogastroduodenoscopy Pilot StudyActive, not recruitingNCT07264738Phase 4
• Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatient Surgical PatientsCompletedNCT07248280Phase 3
• Dexamethasone Versus Metoclopramide for Prophylaxis of Nausea and Vomiting After Cataract SurgeryCompletedNCT07086118Not applicable
• Ondansetron and Dexamethasone for Prevention of PDPH, Nausea, and VomitingCompletedNCT07068230Phase 4
• Efficacy and Safety Study of Aprepitant Injection for Prevention of Post-operative Nausea and VomitingCompletedNCT06932107Phase 3
• The Effect of Hyoscine-n-butylbromide on Nausea and Pain in Laparoscopic CholecystectomyCompletedNCT06927817Phase 4
• Efficacy and Safety of Ondansetron Versus Metaclopromide Treatment in Infants With Gastro Oesophageal RefluxCompletedNCT06898268Not applicable
• Ondansetron vs. Dexamethasone for Postoperative NauseaCompletedNCT06886230Phase 4
• Open Label Safety Study of Tradipitant in Idiopathic and Diabetic GastroparesisCompletedNCT06836557Phase 3
• A Study to Measure the Effects of Using Tradipitant on Nausea and Vomiting After GLP-1R Agonist UseCompletedNCT06804603Phase 2
• Treatment of Women With Hyperandrogenic PCOS With Two Different Ratios of Myo-inositol:D-chiro-inositol: A ComparisonCompletedNCT06715527Not applicable
• Aprepitant and Ondansetron Monotherapy or Combination for Postoperative Nausea and Vomiting in Thyroid CancerCompletedNCT06697782Phase 4
• Peritoneal Lavage Using Saline or Saline With Ondansetron for Pain Control After Laparoscopic CholecystectomyActive, not recruitingNCT06632184Phase 4
• A Comparison Between Palonosetron Versus Granisetron as PONV Prophylaxis in Scoliotic Patients Undergoing Spine SurgeryCompletedNCT06540885Phase 4
• Granisetron Versus Pethidine in Treatment of Post Spinal Shivering in Cesarean SectionsCompletedNCT06513806Phase 4
• Prochlorperazine Maleate Versus Placebo for the Prophylaxis of Acute Mountain SicknessCompletedNCT06450899Phase 2
• Comparative Efficacy of Dexamethasone - Ondansetron Versus Dexamethasone - Haloperidol in Reducing PONVCompletedNCT06428084Phase 2

← Antiemetics overview